EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition

MONDO:1060184

Hereditary cancer predisposition due to variation(s) in the EGLN12 gene, which confers a predisposition to erythrocytosis and pheochromocytoma/paraganglioma.

Also known as: EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition

32 clinical trials for this condition and its sub-types, 0 tagged with EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hereditary neoplastic syndrome (731)

Including sub-types (32) Tagged with EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition (0)

Trials to join now! 15 Not yet recruiting 1 Not yet finished but already full! 10 Completed 6

New online tool aims to help families uncover hidden cancer risks

Knowledge-focused Not yet recruiting

This study tests whether a new online program can help families understand their inherited cancer risk and encourage relatives to get low-cost genetic testing. Researchers will enroll 400 adults who carry a cancer-related gene change and their family members. The goal is to see i…

Sponsor: Stanford University • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:33 UTC

EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition

Where it sits in the disease tree

New online tool aims to help families uncover hidden cancer risks